Shu-Hsia Chen

8PUBLICATIONS
82CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

Yitian Xu, Kyeongah Kang, Brian A Coakley

|Oct 07, 2024
Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment.

Dylan A Goodin, Eric Chau, Junjun Zheng

|Dec 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai, Alan Hodges, Hui-Ming Chen

|Mar 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles.

Yitian Xu, Licheng Zhang, Jose Thaiparambil

|Jul 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.

Kai Sun, Yitian Xu, Licheng Zhang

|Dec 29, 2021
Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome.

Brittany E Jewell, An Xu, Dandan Zhu

Pageof 2

Frequent Collaborators

5 joint publications

Yitian Xu

4 joint publications

Ping-Ying Pan

3 joint publications

Polly Niravath

3 joint publications

Licheng Zhang